Formaldehyde
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB03843 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | leishmaniasis, diffuse cutaneous | KG + DL |
| 2 | cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency | KG + DL |
| 3 | mucocutaneous leishmaniasis | KG + DL |
| 4 | pyelonephritis | KG + DL |
| 5 | streptococcal pneumonia | KG + DL |
| 6 | X-linked lymphoproliferative syndrome | KG + DL |
| 7 | trigonitis | KG + DL |
| 8 | hemophagocytic syndrome associated with an infection | KG + DL |
| 9 | acquired hemophagocytic lymphohistiocytosis associated with malignant disease | KG + DL |
| 10 | Plasmodium falciparum malaria | KG + DL |
| 11 | pyelocystitis | KG + DL |
| 12 | mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | KG + DL |
| 13 | staphylococcus aureus infection | KG + DL |
| 14 | Legionnaires’ disease | KG + DL |
| 15 | ureter tuberculosis | KG + DL |
| 16 | urinary schistosomiasis | KG + DL |
| 17 | mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency | KG + DL |
| 18 | Singleton-Merten syndrome | KG + DL |
| 19 | renal tuberculosis | KG + DL |
| 20 | chronic cystitis | KG + DL |
| 21 | eosinophilic cryptitis | KG + DL |
| 22 | cystitis cystica | KG + DL |
| 23 | hemorrhagic cystitis | KG + DL |
| 24 | Trichomonas cystitis | KG + DL |
| 25 | radiation cystitis | KG + DL |
| 26 | prostatocystitis | KG + DL |
| 27 | papillary cystic neoplasm | KG + DL |
| 28 | Pontiac fever | KG + DL |
| 29 | exocrine pancreatic insufficiency | KG + DL |
| 30 | acute intermittent porphyria | KG + DL |
| 31 | mycobacterium tuberculosis, susceptibility to | KG + DL |
| 32 | classic variant of chromophobe renal cell carcinoma | KG + DL |
| 33 | squamous cell lung carcinoma | KG + DL |
| 34 | polyclonal hyperviscosity syndrome | KG + DL |
| 35 | hyperamylasemia | KG + DL |
| 36 | combined immunodeficiency due to DOCK8 deficiency | KG + DL |
| 37 | childhood malignant kidney neoplasm | KG + DL |
| 38 | cystitis | KG + DL |
| 39 | renal cell adenocarcinoma | KG + DL |
| 40 | bronchiolitis obliterans with obstructive pulmonary disease | KG + DL |
| 41 | disorder of tyrosine metabolism | KG + DL |
| 42 | congenital analbuminemia | KG + DL |
| 43 | lymphoproliferative syndrome | KG + DL |
| 44 | blood group incompatibility | KG + DL |
| 45 | premalignant hematological system disease | KG + DL |
| 46 | hemophagocytic syndrome | KG + DL |
| 47 | acalvaria | KG + DL |
| 48 | susceptibility to infection due to TYK2 deficiency | KG + DL |
| 49 | normophosphatemic familial tumoral calcinosis | KG + DL |
| 50 | papillary adenocarcinoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.